Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine vs Aripiprazole in Attenuated Psychosis Syndrome
NCT02357849Phase 4Terminated
- Sponsor
- Northwell Health
- Start
- Jul 2014
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attenuated psychosis syndrome (APS) comparing Aripiprazole Arm with Fluoxetine Arm (2 arms). Primary endpoint: Time to Treatment Failure at 24 weeks. Started Jul 2014; status: terminated.
02
Drugs
aripiprazolefluoxetine
03
Conditions
attenuated psychosis syndrome (APS)
Beyond the preview
Go deeper on NCT02357849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357849.